1. Executive Summary
2. Industry Outlook
2.1. Industry Overview
2.2. Industry Trends
3. Market Snapshot
3.1. Market Definition
3.2. Market Outlook
3.2.1. Porter Five Forces
3.3. Related Markets
4. Market characteristics
4.1. Market Overview
4.2. Market Segmentation
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. DRO - Impact Analysis
5. Product: Market Size & Analysis
5.1. Overview
5.2. Expanded Carrier Screening
5.2.1. Customized Panel Testing
5.2.2. Predesigned Panel Testing
5.3. Targeted Disease Carrier Screening
6. Technology: Market Size & Analysis
6.1. Overview
6.2. DNA Sequencing
6.3. Polymerase Chain Reaction
6.4. Microarrays
6.5. Others
7. End User: Market Size & Analysis
7.1. Overview
7.2. Hospitals & Clinics
7.3. Reference Laboratories
7.4. Physician Offices
7.5. Others
8. Competitive Landscape
8.1. Competitor Comparison Analysis
8.2. Market Developments
8.2.1. Mergers and Acquisitions, Legal, Awards, Partnerships
8.2.2. Product Launches and execution
9. Vendor Profiles
9.1. Myriad Genetics Inc.
9.1.1. Overview
9.1.2. Financial Overview
9.1.3. Product Offerings
9.1.4. Developments
9.1.5. Business Strategy
9.2. Thermo Fisher Scientific Inc.
9.2.1. Overview
9.2.2. Financial Overview
9.2.3. Product Offerings
9.2.4. Developments
9.2.5. Business Strategy
9.3. PerkinElmer Inc.
9.3.1. Overview
9.3.2. Financial Overview
9.3.3. Product Offerings
9.3.4. Developments
9.3.5. Business Strategy
9.4. Fulgent Genetics Inc.
9.4.1. Overview
9.4.2. Financial Overview
9.4.3. Product Offerings
9.4.4. Developments
9.4.5. Business Strategy
9.5. Quest Diagnostics Incorporated
9.5.1. Overview
9.5.2. Financial Overview
9.5.3. Product Offerings
9.5.4. Developments
9.5.5. Business Strategy
9.6. Invitae Corporation
9.6.1. Overview
9.6.2. Financial Overview
9.6.3. Product Offerings
9.6.4. Developments
9.6.5. Business Strategy
9.7. Illumina Inc.
9.7.1. Overview
9.7.2. Financial Overview
9.7.3. Product Offerings
9.7.4. Developments
9.7.5. Business Strategy
9.8. Natera Inc.
9.8.1. Overview
9.8.2. Financial Overview
9.8.3. Product Offerings
9.8.4. Developments
9.8.5. Business Strategy
9.9. LabCorp
9.9.1. Overview
9.9.2. Financial Overview
9.9.3. Product Offerings
9.9.4. Developments
9.9.5. Business Strategy
9.10. Sema4
9.10.1. Overview
9.10.2. Financial Overview
9.10.3. Product Offerings
9.10.4. Developments
9.10.5. Business Strategy
10. Analyst Opinion
11. Annexure
11.1. Report Scope
11.2. Market Definitions
11.3. Research Methodology
11.3.1. Data Collation and In-house Estimation
11.3.2. Market Triangulation
11.3.3. Forecasting
11.4. Report Assumptions
11.5. Declarations
11.6. Stakeholders
11.7. Abbreviations

TABLE 1. GLOBAL U.S. CARRIER SCREENING MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION)
TABLE 2. GLOBAL U.S. CARRIER SCREENING MARKET VALUE FOR EXPANDED CARRIER SCREENING, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 3. GLOBAL U.S. CARRIER SCREENING MARKET VALUE FOR TARGETED DISEASE CARRIER SCREENING, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 4. GLOBAL U.S. CARRIER SCREENING MARKET VALUE, BY TECHNOLOGY, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 5. GLOBAL U.S. CARRIER SCREENING MARKET VALUE FOR DNA SEQUENCING, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 6. GLOBAL U.S. CARRIER SCREENING MARKET VALUE FOR POLYMERASE CHAIN REACTION, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 7. GLOBAL U.S. CARRIER SCREENING MARKET VALUE FOR MICROARRAYS, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 8. GLOBAL U.S. CARRIER SCREENING MARKET VALUE FOR OTHERS, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 9. GLOBAL U.S. CARRIER SCREENING MARKET VALUE, BY END USER, 2021-2027 (USD BILLION)
TABLE 10. GLOBAL U.S. CARRIER SCREENING MARKET VALUE FOR HOSPITALS & CLINICS, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 11. GLOBAL U.S. CARRIER SCREENING MARKET VALUE FOR REFERENCE LABORATORIES, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 12. GLOBAL U.S. CARRIER SCREENING MARKET VALUE FOR PHYSICIAN OFFICES, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 13. GLOBAL U.S. CARRIER SCREENING MARKET VALUE FOR OTHERS, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 14. U.S. CARRIER SCREENING MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION)
TABLE 15. U.S. CARRIER SCREENING MARKET VALUE, BY TECHNOLOGY, 2021-2027 (USD BILLION)
TABLE 16. U.S. CARRIER SCREENING MARKET VALUE, BY END USER, 2021-2027 (USD BILLION)
TABLE 17. MYRIAD GENETICS INC.: FINANCIALS 
TABLE 18. MYRIAD GENETICS INC.: PRODUCTS & SERVICES 
TABLE 19. MYRIAD GENETICS INC.: RECENT DEVELOPMENTS 
TABLE 20. THERMO FISHER SCIENTIFIC INC.: FINANCIALS 
TABLE 21. THERMO FISHER SCIENTIFIC INC.: PRODUCTS & SERVICES 
TABLE 22. THERMO FISHER SCIENTIFIC INC.: RECENT DEVELOPMENTS 
TABLE 23. PERKINELMER INC.: FINANCIALS 
TABLE 24. PERKINELMER INC.: PRODUCTS & SERVICES 
TABLE 25. PERKINELMER INC.: RECENT DEVELOPMENTS 
TABLE 26. FULGENT GENETICS INC.: FINANCIALS 
TABLE 27. FULGENT GENETICS INC.: PRODUCTS & SERVICES 
TABLE 28. FULGENT GENETICS INC.: RECENT DEVELOPMENTS 
TABLE 29. QUEST DIAGNOSTICS INCORPORATED: FINANCIALS 
TABLE 30. QUEST DIAGNOSTICS INCORPORATED: PRODUCTS & SERVICES 
TABLE 31. QUEST DIAGNOSTICS INCORPORATED: RECENT DEVELOPMENTS 
TABLE 32. INVITAE CORPORATION: FINANCIALS 
TABLE 33. INVITAE CORPORATION: PRODUCTS & SERVICES 
TABLE 34. INVITAE CORPORATION: RECENT DEVELOPMENTS 
TABLE 35. ILLUMINA INC.: FINANCIALS 
TABLE 36. ILLUMINA INC.: PRODUCTS & SERVICES 
TABLE 37. ILLUMINA INC.: RECENT DEVELOPMENTS 
TABLE 38. NATERA INC.: FINANCIALS 
TABLE 39. NATERA INC.: PRODUCTS & SERVICES 
TABLE 40. NATERA INC.: RECENT DEVELOPMENTS 
TABLE 41. LABCORP: FINANCIALS 
TABLE 42. LABCORP: PRODUCTS & SERVICES 
TABLE 43. LABCORP: RECENT DEVELOPMENTS 
TABLE 44. SEMA4: FINANCIALS 
TABLE 45. SEMA4: PRODUCTS & SERVICES 
TABLE 46. SEMA4: RECENT DEVELOPMENTS